CAS No.
739366-20-2(Unlabeled)
Therapeutic Uses
Anti-Diabetic
Synonyms
(S)-N-(2-((2-(2-cyanopyrrolidin-1-yl-2,3,3,4,4,5,5-d7)-2-oxoethyl)amino)-2-methylpropyl)-2-methylpyrazolo[1,5-a]pyrimidine-6-carboxamide
Application Notes
Useful research chemical for a range of applications
Hazard Compound
Refer MSDS for complete information
Useful research chemical for a range of applications
Refund Policy
We are committed to offering products of the highest quality in order to meet the needs of our customers, and have elaborate systems in
place to ensure that material specifications, their certification and all handling and storage conditions are communicated at the time of
material handover.
We have invested in the highest quality packaging materials and use international logistics partners to service our customers. While all
possible precautions have been taken to deliver the required product(s), there may be some rare situations when our product does not
meet your requirements. Should that arise, please contact us with your concerns and we will endeavour to address them on a priority
basis. If there is no other option, we will either replace your product(s) or issue a refund or account credit, whichever you prefer.
If there is an issue with one or more of our products, our policy is that it must be reported to us within 45 days of your receiving shipment.
While we will always address product issues after the 45 day return window has passed, we cannot issue a refund or account credit. As
always, we appreciate your support.
Anagliptin-d7 usage and description
Anagliptin-d7 is a deuterated form of the medication Anagliptin, which is used to treat type 2 diabetes. It is an oral medication that belongs to the class of drugs known as dipeptidyl peptidase-4 (DPP-4) inhibitors. DPP-4 inhibitors work by increasing the levels of incretin hormones in the body, which in turn help to regulate blood sugar levels.
Anagliptin-d7 is a stable isotope-labeled drug that is used in clinical research to study the pharmacokinetics and pharmacodynamics of Anagliptin. It is commonly used in studies that require the use of isotopically labeled compounds, such as drug metabolism and pharmacokinetic studies. Anagliptin-d7 is chemically identical to Anagliptin, except for the substitution of seven deuterium atoms for seven hydrogen atoms.
The chemical formula for Anagliptin-d7 is C20H18D7N5O3, and its molecular weight is 391.48 g/mol. It is typically administered as a tablet, with a recommended dosage of 100 mg once daily. Anagliptin-d7 is metabolized primarily by the liver, and its elimination half-life is approximately 9.9 hours.
Overall, Anagliptin-d7 is an important tool in the study of Anagliptin and its effects on the body. Its chemical properties make it an invaluable resource in clinical research, and its usage has contributed significantly to our understanding of the mechanisms of action of DPP-4 inhibitors.
